Pacing Lead Models SA 350, SAM 500 - SA
by R.E. Brown Co., Inc. 510(k)
Active
510(k) K781619
Overview
The Pacing Lead Models SA 350 and SAM 500 are Permanent Pacemaker Electrodes, designed to deliver electrical stimulation to the heart for cardiac pacing. These leads facilitate the regulation of abnormal heart rhythms by transmitting impulses from a pacemaker device to the cardiac tissue, ensuring proper cardiac conduction.
These leads are intended for use in hospital settings by cardiologists and are supplied sterile for single-use implantation. They are classified as Class III devices under FDA regulations (870.3680) and were granted FDA 510(k) clearance (K781619) under the Traditional review pathway. The models are available in specified configurations for compatibility with cardiac pacing systems, adhering to strict regulatory standards for safety and efficacy.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK781619 | Date8 Dec 1978 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Other devices from R.E. Brown Co., Inc.
Questions
Are these pacing leads designed for reuse in multiple patients, or are they intended for single-use only?
These leads (Models SA 350 and SAM 500) are supplied sterile and explicitly intended for single-use implantation in a hospital setting. The packaging and regulatory classification as Class III devices emphasize their sterile, one-time-use nature to ensure patient safety and compliance with medical device standards.
What types of cardiac pacing systems are these leads compatible with, and how do I determine the correct model for my patient?
The leads (SA 350 and SAM 500) are designed for compatibility with permanent pacemaker systems but come in specified configurations to match particular pacing needs. While the exact models aren’t detailed here, the manufacturer (R.E. Brown Co., Inc.) likely provides compatibility charts or clinical guidance to pair the lead with the appropriate pacemaker device. Always verify with the manufacturer or your device supplier to ensure proper fit for your patient’s pacing requirements.
How should these leads be stored before use, and what are the key considerations for maintaining their sterility?
Since these leads are sterile upon packaging, they must be stored in their original, unopened packaging to preserve sterility. The manufacturer’s instructions (not provided here) would specify environmental conditions like temperature and humidity, but generally, they should be kept in a clean, dry area away from direct sunlight or extreme temperatures. Avoid exposing them to moisture or contamination, as this could compromise their sterile status before implantation.
What is the regulatory pathway these leads follow, and how does that affect their use in clinical practice?
These leads were cleared via the FDA 510(k) Traditional review pathway under the product code DTB (Permanent Pacemaker Electrodes) and are classified as Class III devices (870.3680). This means they undergo rigorous pre-market evaluation to ensure safety and effectiveness for their intended use—delivering electrical stimulation to the heart for cardiac pacing. Clinically, this clearance ensures they meet FDA standards for use in hospital settings by cardiologists, though local hospital protocols and physician training should still govern their specific application.